This article talks about two commentaries by Hayden Rooke-Ley that argue that neoliberal, profit-driven models of U.S. healthcare—particularly privatized Medicare and value-based payment—have failed patients by prioritizing corporate interests over access and quality of care. He calls for a shift to a publicly governed, single-payer system that removes financial conflicts of interest and restores decision-making to non-commercial entities and caregivers.

This piece, authored by Hayden Rooke-Ley, argues that while the Trump administration’s One Big Beautiful Bill Act threatens to gut Medicaid funding by nearly $1 trillion over a decade, states still have powerful tools to protect coverage and even strengthen their healthcare systems. By capping inflated prices in the private insurance market and redirecting those savings to Medicaid—where every dollar is federally matched—states can blunt the impact of federal cuts, support vulnerable providers, and reduce systemic inequities.

The article investigates how major drugmakers like Pfizer and Eli Lilly are paying telehealth companies millions of dollars to connect patients to providers, raising concerns about potential conflicts of interest and violations of anti-kickback laws. While both companies deny influencing prescriptions, lawmakers and experts worry these partnerships may steer patients toward expensive branded drugs and allow pharma firms to collect detailed patient data.

This article covers a study in JAMA Health Forum finds that private equity-acquired gastroenterology practices significantly raised colonoscopy prices without any improvement in quality of care. The rise in costs was especially steep in highly consolidated markets, where prices surged by 6.7%. With no measurable gains in patient outcomes, the findings raise broader concerns about the impact of PE’s profit-driven model on healthcare affordability, transparency, and value.

This article argues that despite Massachusetts’ recent reforms after the collapse of Steward Health Care, a major loophole still allows private equity to control medical practices through shell companies and “friendly physician” arrangements. Drawing on the century-old corporate practice of medicine (CPOM) doctrine, the article calls for stronger legal restrictions like those recently passed in Oregon to protect patient care from financial interests.

This article reports on a study by Daniel R. Arnold, and colleagues who find that private equity-acquired gastroenterology practices significantly increase colonoscopy prices—by 4.5% more than independent practices—without improving care quality. Despite claims that consolidation boosts efficiency, the analysis showed no statistical difference in quality measures, raising concerns about affordability and access.

A bipartisan group of lawmakers has introduced legislation to stop Medicare Advantage insurers from collecting billions in federal payments for veterans who primarily receive care through the VA. Sparked by a Wall Street Journal investigation—supported by data from Brown University researchers—the bill aims to close a loophole that enabled an estimated $44 billion in excess payments from 2018 to 2021.

This article reports on a FTC study highlighting how roll-up acquisitions of physician practices—often led by private equity firms—can harm competition, raise prices, and reduce care quality. The study calls for increased scrutiny of serial acquisitions that fall below federal reporting thresholds, and experts say it could lead to stronger antitrust enforcement in healthcare markets.

This article discusses how financial pressures, staffing shortages, and management decisions at Wisconsin’s Group Health Cooperative have led to a unionization effort by primary care providers, reflecting broader national challenges facing independent primary care.

Several states are adopting hospital price caps to curb rising healthcare costs, citing limited success from other reforms. Supporters see savings, while hospitals warn of revenue loss and service cuts. See what CAHPR's Roslyn Murray, PhD has to say.

Nominated by Arnold Ventures, Dr. Singh joined over 100 global fellows in Colorado in June 2025 to explore how market forces are reshaping health care at this year’s “Payoff: Investing in Health” conference by the Aspen Institute.

This news video features Dr. Andrew Ryan, Director of CAHPR, discussing his study on Rhode Island’s hospital affordability standards, which led to significant hospital price and premium reductions—saving $1,000 per fully insured member by 2022.

Professors Erin Fuse Brown and Yashaswini Singh warn that private equity’s focus on short-term returns is reshaping healthcare at the expense of patients and providers. From overburdened hospitals to ethical dilemmas in mental health care, their insights expose how profit-driven ownership can undermine clinical priorities and public trust.

This article reports on a study by CAHPR researchers that found that Rhode Island’s 2010 hospital price growth cap significantly reduced hospital prices and lowered premiums for fully insured health plans by $1,000 per member annually by 2022. However, the policy had limited impact on the self-insured market due to federal ERISA regulations, and the resulting hospital revenue losses have raised concerns about financial sustainability and care quality.

The article discusses how home health care workers in Rhode Island are fighting for better wages and working conditions through unionization, but their efforts are at risk due to proposed federal Medicaid cuts. David J. Meyers, a health economist at Brown University, warns that such cuts could have a “massive, qualitative impact on people’s lives” and ultimately increase health care spending as unmet needs at home lead to more hospitalizations and emergency visits.

The article discusses Dr. Ateev Mehrotra, chair of the Brown SPH Department of Health Services, Policy and Practice, and his concerns that ongoing temporary telehealth policies are stifling innovation and investment, as he urges permanent federal solutions to ensure long-term access and growth.

A Nevada bill aims to cap hospital fees for the Public Employees’ Benefits Program to reduce costs, drawing on Oregon's model, which researcher Roslyn Murray of Brown University studied and found led to significant savings without shifting costs to private insurers.

The article discusses the looming expiration of pandemic-era Medicare telehealth expansions and the ongoing policy debate over their extension, including new research by Ateev Mehrotra and Jared Perkins who suggest that lowering reimbursement rates for telehealth could make its permanent expansion more financially and politically viable.

Congress recently extended Medicare’s telehealth flexibilities until March 31, 2025, but the lack of permanent reform creates uncertainty for providers and patients. A long-term solution is needed to sustain telehealth’s benefits, ensure continued access, and drive innovation in health care.

This news article highlights the study led by Dr. Roslyn Murray on potential savings achieved by capping state employee health plans while discussing how rising health care costs are squeezing state dollars.

The Trump administration's push for deregulation threatens to accelerate vertical integration in healthcare. Brown University professor, Dr. Christopher Whaley warns from existing research how this may lead to referrals to more expensive hospitals ultimately leading to higher costs, reduced competition, and financial strain on independent hospitals, particularly in rural areas as the article discusses.

This article talks about the analysis conducted by CAHPR researchers who find that routine medical care costs four times more in New York’s outpatient hospital facilities than in doctor’s offices, largely due to added facility fees. Economist Christopher Whaley and other experts have long highlighted such pricing disparities, fueling legislative efforts like the proposed Fair Pricing Act to cap these costs.

Gloria Sachdev has spent years challenging high hospital prices in Indiana, successfully pushing for healthcare cost transparency and legislative reforms. Her efforts, have led to a national report on hospital pricing and significant policy changes in the state.

This article covers a Brown University study, published in Health Affairs, which found that the Colorado Option lowered average marketplace premiums by $101 per month since 2020, while exchange premiums nationally rose by 10%.

The article covers a study published in JAMA Health Forum by Yashaswini Singh and colleagues on the increasing affiliation of primary care physicians with hospitals and private equity firms, leading to higher patient costs without clear improvements in care quality or physician compensation.

This article covers criticisms from Colorado’s Health Care Future, which argues that the program has failed to lower premiums, harmed competition, and reduced consumer choices, while the state cites a Brown University analysis showing it provides affordable coverage and limits premium increases driven by rising hospital and provider costs.

This article talks about two conflicting studies on the Colorado Option emerged—one, funded by the insurance industry, found only 2% of plans met the 10% premium reduction goal, while another, by Brown University researchers and backed by the Commonwealth Fund, highlighted it as a model, estimating $100 lower premiums than similar states without a public option.

This article discusses a study led by Dr. Yashaswini and published in JAMA Health Forum on trends in physician practice ownership, showing a significant shift from independent practices to corporate ownership, as well as the associated price increases, with hospital and PE-affiliated practices charging higher fees, and its implications for healthcare costs and quality.

This article highlights the study led by Dr. Yashaswini Singh on the growing affiliation of primary care physicians with hospitals and private equity firms along with increasing healthcare costs that come with these affiliations.

Physicians, traditionally less unionized, are aligning with nurses and other healthcare workers due to shared grievances over understaffing, burnout, and corporate cost-cutting practices exacerbated by the pandemic. Hayden Rooke-Ley comments on this trend highlighting his study that found that the number of physician unions formed between January 2023 and May 2024 nearly equaled those established over the previous two decades (2000–2022).

Jared Perkins, Director of Health Policy Strategy at CAHPR discusses bridging the gap between academia and policymakers, the challenges of navigating health policy under a shifting political climate, and the importance of aligning research with legislative priorities.

A new Harvard Medical School study found that patient satisfaction declines after PE takeovers due to cost-cutting measures, including staffing reductions. Dr. Yashaswini Singh from CAHPR comments on how patient experiences are crucial to understanding the broader effects of PE in healthcare, a frequently underrated aspect in studies on PE's impact on healthcare.

The article discusses the proposed merger of Oregon Health & Science University (OHSU) and Legacy Health, which has drawn significant criticism for potentially violating federal antitrust standards. Advocates argue the merger would lead to excessive market consolidation in Oregon, controlling a majority of hospitals in key regions and potentially driving up healthcare costs without improving access or quality.

This article highlights a study led by Dr. Christopher Whaley that shows that while system affiliation helps improve CAHs’ financial stability, it often results in higher prices for patients.

This article explores the study by researchers from Johns Hopkins University and CAHPR at Brown University, which examines financial disparities between critical access hospitals (CAHs) and larger acute care hospitals from 2016 to 2022. The study highlights significant financial disparities, showing that system-affiliated critical access hospitals (CAHs) achieved higher operating margins than independent ones and highlights the need to balance financial sustainability with the risks of uneven care access and higher prices.

This news article covers the study led by CAHPR researchers who found that state employee health plans could save over $7 billion annually by capping hospital payments at 200% of Medicare rates. The findings suggest that such caps could ease budgetary pressures while minimizing disruptions to hospital operations.

This article dives into the controversial world of private equity in healthcare, where profit-driven strategies lead to higher patient costs and declining care quality. This article examines real examples, from staffing cuts to surprise billing, and explores how these changes threaten physician autonomy and the stability of U.S. healthcare.

This news article offers continued coverage on the impact of hospital payment caps and the potential for nationwide savings, based on the Health Affairs study led CAHPR researchers at the Brown University School of Public Health.

This news article provides continued coverage of the study by CAHPR researchers on hospital payment caps, and it's potential for saving billions without harming hospital finances.

The article examines California’s failed attempt to regulate private equity investments in healthcare through AB 3129, which proposed stricter transaction oversight and protections against corporate control of medical practices. It critiques the bill’s limited scope, exemptions, and political challenges while positioning it as a case study for future state-level reforms in addressing healthcare consolidation.

This article highlights a study by Christopher Whaley showing how hospitals have received billions in extra payments by documenting care at higher levels of complexity than expected. This practice, known as "upcoding," raises concerns about the incentives in current payment systems and their impact on rising healthcare costs.

The article written by CAHPR researchers, emphasizes the opportunity for Congress, in its final weeks of the 118th session, to advance healthcare affordability and transparency through the Lower Costs, More Transparency Act (LCMT) and the Health Care PRICE Transparency Act 2.0

UnitedHealth Group's insurance arm, UnitedHealthcare, pays its own Optum physician practices significantly higher rates than other providers in the same markets, driving up costs for consumers and employers while enriching itself. This practice highlights the conflicts of interest and anti-competitive effects of vertical integration in healthcare, raising calls for regulatory intervention.

Is Medicare Advantage improving healthcare efficiency or creating higher costs that favor insurers? Hayden Rooke-Ley explores its rapid expansion, questions about cost and care quality, and the challenges of implementing effective regulations.

This article outlines six key points about Oregon's regulatory review of the OHSU-Legacy merger. Hayden Rooke-Ley's critique of the OHSU-Legacy merger, emphasizing how OHSU's broad market definition may obscure significant anticompetitive risks, presenting a critical test for Oregon's Health Care Market Oversight program.

An increasing number of Medicare Advantage patients, especially those in their final year of life, are switching to traditional Medicare, leading to a significant cost shift from private insurers to taxpayers.

This article examines the Oregon Health Authority's comprehensive review of the proposed merger between OHSU and Legacy Health, highlighting key concerns about market concentration, potential cost increases, and the future of health care access and competition in the region.

This article examines lawsuits from Medicare Advantage insurers, who claim minor customer service issues threaten millions in bonuses, while experts like Brown University's David Meyers argue that these cases reveal deeper flaws in a rating system that overstates plan quality without accurately reflecting patient care.

This article explores a study led by Brown University researchers on the billions in potentially redundant payments Medicare Advantage plans receive for veterans primarily cared for by the VA, despite industry claims, like those from UnitedHealthcare, that these payments reflect actual costs.